Catalyst Wire Dossier Catalyst Wire Dossier

Misoprostol vaginal insert (MVI 200)

misoprostol · Ferring Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Misoprostol vaginal insert (MVI 200), covering 2014-04-14 to 2014-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study) [Phase 2]

See pricing